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Abstract
Background: Although an antecolic duodenojejunostomy was reported to reduce post-operative
delayed gastric emptying (DGE) compared with a retrocolic duodenojejunostomy after a pylorus-
preserving pancreaticoduodenectomy (PPPD), the long-term effects of these procedures have rarely been
studied. The aim of this prospective, randomized, clinical trial was to investigate the influence of the
reconstruction route on post-operative gastric emptying and nutrition.
Methods: Reconstruction was performed in 116 patients with an antecolic duodenojejunostomy
(A group, n = 58) or a vertical retrocolic duodenojejunostomy (VR group, n = 58). Post-operative
complications, including DGE, gastric emptying variables assessed by 13C-acetate breath test and
nutrition, were compared between the two groups for 1 year post-operatively.
Results: The incidence of DGE was not significantly different between the procedures (A group: 12.1%;
VR group: 20.7%, P = 0.316). At post-operative month 1, gastric emptying was prolonged in the VR versus
the A group but not significantly so. At post-operative month 6, gastric emptying was accelerated
significantly in the A versus the VR group. Post-operative weight recovery was significantly better in the
VR versus the A group at post-operative month 12 (percentage of pre-operative weight, A group: 93.8 
1.2%; VR group: 98.5  1.3%, P = 0.015).
Conclusions: A vertical retrocolic duodenojejunostomy was an acceptable procedure for the lower
incidence of DGE and may contribute to better weight gain affected by moderate gastric emptying.
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Introduction
A pylorus-preserving pancreaticoduodenectomy (PPPD) is the
standard operation for peri-ampullary disease. Although opera-
tive mortality of PPPD has been reduced to less than 5%,1–4 post-
operative morbidity remains high, at 30% to 60%.2–4 Delayed
gastric emptying (DGE) is one of the most specific and frustrating
complications after PPPD, with an incidence ranging from
5–60%.4,5 DGE is self-limiting and can be treated conservatively;
however, this complication leads to a prolonged hospital stay and
worsens the patient’s quality of life.
Two reconstruction methods after PPPD are associated with the
transverse colon: an antecolic duodenojejunostomy and a retro-
colic duodenojejunostomy. An antecolic duodenojejunostomy is
reported to offer equal or superior outcomes for the prevention of
DGE compared with the retrocolic route.6–11 The reported inci-
dence of DGE with the antecolic route is below 15%, whereas that
with the retrocolic route is above 30%. The incidence of DGE
reported by these studies for reconstruction by the retrocolic route
was considered to be high compared with the authors’ experience.
The authors reported previously that a vertical retrocolic duode-
nojejunostomy, by which the stomach and duodenum are brought
down the left side of the transverse mesocolon in a straight, ver-
tical manner, reduces the incidence of DGE.12,13 However, the
number of the patients was small and the period after PPPD was
short in these two studies.
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The aim of the present study was to perform a prospective,
randomized, clinical trial to compare the incidence of DGE
assessed according to the definition of the International Study
Groups of Pancreatic Surgery (ISGPS)14 in 116 patients undergo-
ing either an antecolic duodenojejunostomy or a vertical retro-
colic duodenojejunostomy. Although some studies reported to
notice an association between DGE and reconstruction route, the
post-operative effects on gastric emptying function and nutri-
tional status have rarely been compared between the two recon-
struction methods. Therefore, in this study, nutritional status and
gastric emptying variables assessed by the 13C-acetate breath
test15–17 were compared before and at 1, 3, 6, 9 and 12 months
during the first year after surgery between the two reconstruction
methods.
Methods
The study protocol was approved by the ethics committee of
Miyazaki University, Miyazaki, Japan, and was registered with the
National Clinical Database (University Hospital Medical Informa-
tion Network Clinical Trials Registry as UMIN000001712). From
March 2005 until July 2011, 129 patients underwent a PPPD at the
Department of Surgical Oncology and Regulation of Organ Func-
tion, Miyazaki University School of Medicine. The patients who
underwent a pancreaticoduodenectomy with gastric resection,
subtotal stomach-preserving PD (SSPPD), additional hepatic
resection and a total pancreatectomy were excluded from the
study. The patients underwent standard pretreatment evaluation,
randomization to an antecolic or a vertical retrocolic duodenoje-
junostomy, and assessment of the results, DGE, gastric emptying
and nutritional status for 1 year after surgery. Patients were
recruited into the study before surgery, and informed consent was
obtained from all participants. The study flow chart is shown in
Fig. 1. Because of their pre-operative condition, four patients who
did not give their informed consent and five patients with severe
comorbidity were excluded. The remaining 120 patients under-
went randomization; however, four patients with post-operative
severe sepsis (two undergoing each reconstruction method) were
excluded. A re-operation was performed in one patient (0.8%) in
the antecolic group for ischaemic perforation of the duodenoje-
junostomy. Post-operative mortality occurred in two patients
(1.7%), one patient in the antecolic group as a result of sepsis from
an intravenous catheter infection, and one patient in the vertical
retrocolic group owing to liver failure associated with a vascular
problem. Thus, the remaining 116 patients were divided into two
groups: the antecolic group (A group, n = 58) and the vertical
retrocolic group (VR group, n = 58).
All patients underwent detailed pre-operative physical exami-
nation with haematological and biochemical assessment includ-
ing measurement of tumour markers. The indication for surgery
for all patients was suspected peri-ampullary lesion on the basis of
computed tomography and additional imaging studies. Patients
with distant metastases or locally far advanced tumours were
judged to be inoperable. Patients with jaundice underwent pre-
operative endoscopic or percutaneous transhepatic biliary drain-
age to decrease their serum bilirubin level. Pre-operative diabetes
mellitus was assessed by the serum haemoglobin A1c level, fasting
plasma glucose level, random glucose level and the oral glucose
tolerance test. All patients except those with established diabetes
mellitus were referred for oral glucose tolerance testing.
Prior to the surgeries, equal numbers of envelopes for an
antecolic or a vertical retrocolic duodenojejunostomy were
sequentially prepared in a blinded fashion to rule out any influ-
ence of bias in the choice of reconstruction technique during
surgery.
The same team of surgeons performed all operations. The area
resected during the PPPD included the gallbladder, common
hepatic duct, pancreas head, duodenum (except the first portion)
and 10 cm of the proximal jejunum. Lymph nodes in the hepa-
toduodenal ligament and those surrounding the common hepatic
artery, peripancreatic tissue and the right side of the superior
mesenteric artery were dissected. If necessary, combined portal
vein resection or dissection of paraaortic lymph nodes was per-
formed to accomplish a complete tumour resection. The duode-
num was freed from the surrounding tissue and transected
approximately 2–4 cm distal to the pyloric ring. The right gastric
artery was divided at its origin in all patients. The lesser omentum
close to the liver was dissected while preserving the vagus nerve to
allow free movement of the stomach. These procedures allowed
the stomach and the duodenum to be mobilized to the left in a
straight, vertical manner. In reconstruction, the proximal jejunum
was brought through the right side of the transverse mesocolon
via the retrocolic route. An end-to-side pancreaticojejunostomy
was performed with duct-to-mucosa anastomosis. A hepaticoje-
junostomy was performed 5–10 cm distal to the pancreaticojeju-
nostomy. Then, an end-to-side duodenojejunostomy was
performed about 50 cm distal to the hepaticojejunostomy based
on randomization to either the antecolic or vertical retrocolic
route. For vertical retrocolic duodenojejunostomy, the left side of
the transverse mesocolon (to the left of the middle colic vessels)
was opened, and the stomach and duodenum were brought down
in a straight, vertical manner. The retrocolic duodenojejunostomy
was performed at the caudal side of the transverse mesocolon, and
the gastric antrum was fixed to the transverse mesocolon with
several sutures. A Braun anastomosis was added in both recon-
struction procedures. A schema of the reconstruction techniques
used for both procedures is shown in Fig. 2. Two (or three) closed
drains were placed around the pancreatic and biliary anastomoses.
A pancreatic drainage tube and a biliary drainage tube were placed
at the pancreatic duct and hepatic duct, respectively, and were
exteriorized through the jejunal limb. A feeding tube was not
placed in any of the patients.
All patients received prophylactic antibiotics for 2 to 3 days
post-operatively. The patients were given epidural anaesthesia for
4–5 days post-operatively and/or adequate analgesia, and early
ambulation was encouraged. The general protocol for patient care
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was to remove the nasogastric tube (NGT) routinely on postop-
erative day (POD) 1 if the gastric amount was below 500 ml after
the first post-operative night. If the patients vomited persistently
after removal of the NGT, it was reinserted. The drinking of water
was started from POD 3, and a liquid diet was commenced on
POD 4, with progression to a soft diet as tolerated. The drains
were checked for amylase every day from POD 1 to POD 5 and
were removed if there was no evidence of any pancreatic or biliary
leakage. A proton pump inhibitor was administered intravenously
after surgery and converted to an oral dose once a diet was toler-
ated. Pancreatic enzyme supplements were prescribed once a soft
diet was commenced. No patient was given prokinetic drugs such
as erythromycin or octreotide. Parenteral nutrition was used in
the patients with insufficient dietary intake owing to postopera-
tive complications and was discontinued if the patients could
tolerate more than half of their oral diet.
Post-operative complications
All resected specimens underwent definitive histological study
after surgery. All patients with malignant disease underwent a
gross complete (R0 or R1) resection. Post-operative complications
were evaluated in all 116 patients (58 in each group). According to
the ISGPS consensus criteria, DGE was defined by the need for
maintenance or reinsertion of the NGT after POD 3 or inability to
tolerate a solid diet after POD 7. The severity of DGE was classi-
fied into grades A, B, and C by the length of need for the NGT or
129 patients underwent PPPD
120 patients were randomized
58 patients were analyzed 58 patients were analyzed
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Figure 1 Participant flow chart
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inability to tolerate a solid diet, and clinical impact.14 A pancreatic
fistula was defined and graded according to the International
Study Groups on Pancreatic Fistula (ISGPF) definition, and clini-
cally relevant a pancreatic fistula was defined as grade B or C.18A
post-pancreatic surgery haemorrhage was defined according to
the ISGPS definition.19 An intra-abdominal abscess was defined as
culture-positive purulent drainage or findings of intra-abdominal
fluid collection by computed tomography accompanied with fever
elevation or leukocytosis. Mortality was defined as the patient
death occurring until POD 30.
Gastric emptying and nutritional status for 1 year
after surgery
Gastric emptying function was evaluated pre-operatively and at
months 1, 3, 6, 9, and 12 post-operatively using the 13C-acetate
breath test.15–17 A proton pump inhibitor was not given for 3 days
before the test. All patients ingested a liquid meal (200 Kcal/
200 ml, RACOL; Ohtsuka Pharmaceutical Co., Tokyo, Japan)
labelled with 100 mg sodium 13C-acetate (Cambridge Isotope
Laboratories, Inc., Andover, MA, USA) in the morning of the test
day after an overnight fast. Breath samples were collected in the
collection bag before and after ingestion of the test meal, i.e.
before and at 5, 10, 15, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150 and
180 min after ingestion of the 13C-acetate. The recovery of 13C in
the breath samples was analyzed by isotope-selective infrared
spectrometry (UBiT-IR300; Otsuka Electronics Co., Ltd, Osaka,
Japan). Gastric emptying was estimated by the values of the time
when 13CO2 reaches maximum excretion (T max), half-emptying
time (T 1/2) and total % excretion of 13CO2 in 2 h (%dose/2 h).
These values were calculated with analysis software (Microsoft
Office Excel; Microsoft Japan, Tokyo, Japan) from a calculated
13CO2 breath excretion curve.
Follow-up at intervals of least every 3 months comprised a
physical examination, laboratory tests including tumour markers,
computed tomography, estimation of tumour recurrence and sur-
vival. All 58 patients in each group received 13C-acetate breath test
as the measure of gastric emptying function, but patients with
tumour recurrence were excluded at that point as subjects for
assessment of nutritional status and 13C-acetate breath test. In
addition, any patients whose treatment required hospital admis-
sion or a laparotomy for another disease and those who could not
be followed up at the study institution because they had moved to
a different location were excluded at the follow-up evaluation. The
number of the patients excluded and the reasons for exclusion are
shown in Fig. 1.
Data collection and study end points
The patients’ clinicopathological and follow-up data were col-
lected prospectively. The primary end point was the incidence of
DGE. Secondary end points were post-operative complications
except DGE, evaluation of gastric emptying and nutritional status
for 1 year after surgery.
Statistical analysis
For statistical analysis of post-operative complications, especially
DGE, a power calculation indicated that 58 patients needed to be
enrolled for each procedure to test the premise of improving the
rate of DGE from 30% to 10% at the two-tailed significance level
of 5% with a power of 80%. Results are reported as median
(range) or mean  standard error (SE). In comparisons between
the A and VR groups, categorical variables were compared with
chi-square test or Fisher’s exact test, quantitative variables with
the Student t-test, and non-parametric variables with the
(a) (b)
Figure 2 Schema showing reconstruction techniques after a pylorus-preserving pancreaticoduodenectomy. (a) Antecolic duodenojejunos-
tomy. (b) Vertical retrocolic duodenojejunostomy
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Mann–Whitney U-test. In addition, Dunnett’s post hoc test was
used to compare change from the baseline (preoperative) value for
the post-operative parameters of gastric emptying and nutritional
status for 1 year after surgery. The level of significance was set at
P < 0.05.
Results
Clinical characteristics and operative findings of the enrolled
patients are shown in Table 1. There were no statistically signifi-
cant differences between the two groups with regards to age,
gender ratio, body mass index, pre-operative body weight, the
presence of diabetes mellitus, pre-operative nutritional bioche-
mical parameters, pancreatic endocrine and exocrine function,
pre-operative biliary drainage and type of disease (benign or
malignant). The duration from presentation of disease to opera-
tion was also not significantly different between the two groups.
Operative findings including operation time, operative blood loss,
soft pancreas and portal vein resection were similar between the
two groups (Table 1).
Table 1 Characteristics of patients and operative findings
Antecolic (A) group
(n = 58)
Vertical retrocolic (VR)
group (n = 58)
P-value
Age (years)a 70.0 (36–86) 69.0 (46–86) 0.540
Gender (male/ female) 36 (62.1%)/ 22 (37.9%) 32 (55.2%)/ 26 (44.8%) 0.451
Body mass index (kg/m2)a 21.8 (15.7–29.0) 21.3 (14.7–29.3) 0.463
Pre-operative body weight (kg)a 53.9 (35.6–78.8) 51.9 (30.5–75.8) 0.338
Diabetes mellitus 21 (36.2%) 21 (36.2%) 1.000
Pre-existing on admission 11 (19.0%) 7 (12.1%) 0.442
Newly diagnosed 10 (17.2%) 14 (24.1%) 0.359
Insulin dependant 4 (6.9%) 5 (8.6%) 0.729
Oral administration 9 (15.5%) 5 (8.6%) 0.393
Pre-operative albumin (g/dl)a 3.75 (2.94-4.78) 3.66 (2.69-4.48) 0.542
Pre-operative total cholesterol (mg/dl)a 177 (92–381) 181 (115–372) 0.204
Pre-operative haemoglobin-A1c (%)a 5.3 (3.6–11.0) 5.2 (3.9–10.9) 0.968
Pre-operative BT-PABA test (%)a 56.6 (10.6–82) 53.0 (12.9–87.4) 0.506
Pre-operative biliary drainage 38 (65.5%) 43 (74.1%) 0.312
Length of time from presentation of disease
to operation (weeks)a
8 (3–36) 8 (4–21) 0.349
Pathology
Benign/ malignancy 12 (20.7%)/ 46 (79.3%) 9 (15.5%)/ 49 (84.5%) 0.425
Pancreatic cancer 17 (29.3%) 16 (27.6%)
Bile duct cancer 17 (29.3%) 20 (34.5%)
Ampullary carcinoma 4 (6.9%) 9 (15.5%)
Duodenal cancer 2 (3.4%) 0
Cystic tumour (IPMN, MCN) 11 (19.0%) 6 (10.3%)
Chronic pancreatitis 2 (3.4%) 3 (5.2%)
Benign bile duct disease 2 (3.4%) 2 (3.4%)
Others 3 (5.2%) 2 (3.4%)
Operative findings
Operating time (minutes)a 558.0 (427–967) 571.5 (422–769) 0.712
Operative blood loss (ml)a 1380 (360–6870) 1295 (230–3980) 0.440
Blood transfusion 36 (62.1%) 30 (51.7%) 0.261
Soft pancreas 32 (55.2%) 35 (60.3%) 0.573
Main pancreatic duct diameter (mm)a 4 (2–10) 3 (2–10) 0.467
Resected duodenum (cm)a 4 (2–4) 4 (3–4) 0.064
Portal vein resection 8 (13.8%) 4 (6.9%) 0.223
aResults are expressed as median (range).
BT-PABA, N-benzoyl-L-tyrosyl-para-aminobenzoic acid; IPMN, intraductal papillary mucinous neoplasm; MCN, mucinous cystic neoplasm.
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Post-operative complications
Post-operative complications before discharge from the hospital
are shown in Table 2. Surgical morbidity between the two
groups was not significantly different: 50.0% in the A group and
44.8% in the VR group. The overall incidence of clinically rel-
evant pancreatic fistula (ISGPF grade B or C) occurred in 19
patients (16.4%). The incidence of all-grade pancreatic fistula
was 37.9% in the A group and 29.3% in the VR group, and clini-
cally relevant pancreatic fistula (ISGPF grade B or C) was 15.5%
in the A group and 17.2% in the VR group, both without a
statistically significant difference between the two groups. An
intra-abdominal abscess occurred in 29 patients (25.0%), and
the difference between the two groups was not statistically
significant.
Delayed gastric emptying
The overall incidence of DGE was 16.4% (19 of 116 patients)
(Table 2). The DGE grades of these patients were A in 10, B in 1
and C in 8 patients. In A group, the incidence of DGE was 12.1%
(7 of 58 patients), and the grades were A in 4, B in 1 and C in 2
patients. In the VR group, the incidence of DGE was 20.7% (12 of
58 patients), and the grades were A in 6, B in 0 and C in 6 patients.
Although the incidence of DGE tended to be higher in the VR
versus the A group, the difference was not statistically significant
(P = 0.316). The incidence of clinically relevant DGE (grades B
and C) was 5.2% (3 patients) in the A group and 10.3% (6
patients) in the VR group, and the difference was still not statis-
tically significant (P = 0.298). Clinical parameters related to DGE
are shown in Table 2. The day of NGT removal was similar, on
Table 2 Post-operative complications, including clinical parameters related to delayed gastric emptying (DGE), and post-operative course
Antecolic (A) group
(n = 58)
Vertical retrocolic
(VR) group (n = 58)
P-value
Morbidity 29 (50.0%) 26 (44.8%) 0.577
Pancreatic fistula (PF) 22 (37.9%) 17 (29.3%) 0.326
ISGPF grading (A/B/C) 13/6/3 7/8/2
ISGPF grade B/C 9 (15.5%) 10 (17.2%) 0.802
Intra-abdominal abscess 16 (27.6%) 13 (22.4%) 0.520
Post-operative haemorrhagea 3 (5.2%) 3 (5.2%) 1.000
Biliary leakage 1 (1.7%) 0 0.315
Wound infection 9 (15.5%) 9 (15.5%) 1.000
Peptic ulcer 2 (3.4%) 1 (1.7%) 0.559
Cholangitis 5 (8.6%) 3 (5.2%) 0.464
DGE 7 (12.1%) 12 (20.7%) 0.316
ISGPS grading (A/B/C) 4/1/2 6/0/6
ISGPS grade B/C 3 (5.2%) 6 (10.3%) 0.298
Clinical parameters related to DGE
Removal of NGT (day)b 1 (0–2) 1 (0–20) 0.729
Removal of NGT as per protocol 55 (94.8%) 55 (94.8%) 1.000
Reinsertion of NGT 0 1 (1.7%) 0.315
Start of water drinking (day)b 3 (3–17) 3 (2–21) 0.833
Start of liquid diet (day)b 4 (4–37) 4 (4–28) 0.633
Start of solid diet (day)b 5 (5–38) 5.5 (5–29) 0.258
Start and progression of diet as per protocol 44 (75.9%) 42 (72.4%) 0.672
Duration of parenteral nutrition (days)b 11 (5–43) 14 (7–35) 0.097
Parenteral nutrition over 2 weeks 19 (32.8%) 21 (36.2%) 0.696
Post-operative course
Hospital stay (days)b 36 (27–116) 36 (23–75) 0.910
Adjuvant chemotherapy 30 (51.7%) 29 (50.0%) 0.851
Tumour recurrence in 1st postoperative year 18 (31.0%) 12 (20.7%) 0.203
aPost-pancreatic surgery haemorrhage was defined according to the ISGPS definition.
bResults are expressed as median (range).
DGE, delayed gastric emptying; ISGPF, International Study Groups on Pancreatic Fistula; ISGPS, International Study Groups of Pancreatic Surgery;
NGT, nasogastric tube.
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median POD 1 in both groups. Only one patient in the VR group
required reinsertion of the NGT, and the patient improved with
conservative treatment and without additional interventions. The
number of days to the start of liquid and solid diets, the duration
of parenteral nutrition, and length of hospital stay were not sig-
nificantly different between the two groups.
Changes in gastric emptying variables for
1 year after surgery
Results of the gastric emptying variables from the 13C-acetate
breath test for 1 year after surgery are shown in Fig. 3. An increase
in T max (the time when 13CO2 reaches maximum excretion) and
in T 1/2 (half-emptying time) indicates prolonged gastric empty-
ing, and an increase in %dose/2h (total % excretion of 13CO2 in
2 h) indicates accelerated gastric emptying.
The value of T max was significantly prolonged at post-
operative month 1 in comparison with the pre-operative value in
both groups. The value of T max in the VR group was greater than
that in the A group at post-operative month 1, but it was not
significantly different (A group: 1.50  0.14 h, VR group: 1.79 
0.23 h, P = 0.593). The values of T max at post-operative months
3, 6, 9, and 12 were equal to or shorter than the pre-operative
values in both groups, and there were no significant differences
between the two groups. Similarly, the value of T 1/2 was
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Figure 3 Post-operative change in parameters related to the 13C-acetate breath test: (a) the time when 13CO2 reaches maximum excretion
(T max), (b) half-emptying time (T 1/2), and (c) total % excretion of 13CO2 in 2 h (%dose/2 h). Values are mean  standard error. *P < 0.05
for comparison of each post-operative time point value with the pre-operative value in the same group. **P < 0.05 for comparison of
the antecolic (A) group with the vertical retrocolic (VR) group. There were no significant differences at any time points compared between
the two groups in (a) and (b), except for (c). Comparisons between the values of each time point and the pre-operative value showed the
following. (a) The values at post-operative month 1 were significantly greater than the pre-operative values for each group. (b) The values
at post-operative month 1 were significantly greater than the pre-operative values for each group. (c) The value at post-operative month 6
in the A group was significantly greater than the pre-operative value. The values were greater in the A group than in the VR group at every
time point, and the difference was significant at month 6 after surgery (A group: 42.9  1.0%, VR group: 38.7  1.1%, P = 0.001)
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significantly prolonged at post-operative month 1 in comparison
with the pre-operative value in both groups. The value of T 1/2 in
the VR group was greater than that in the A group at post-
operative month 1, but the difference was not statistically sig-
nificant (A group: 3.37  0.37 h, VR group: 5.55  1.10 hours,
P = 0.164). Post-operative changes in the value of T 1/2 gradually
decreased as time passed, but the difference was not significant
between the two groups. The value of %dose/2h was higher in the
A group than in the VR group at all post-operative time points
and was significantly higher at post-operative month 6 (A group:
42.9 1.0%, VR group: 38.7 1.1%, P = 0.001). Collectively, the
VR group showed prolonged gastric emptying without a signifi-
cant difference in the short term post-operatively (post-operative
month 1). Both groups showed prolonged gastric emptying at
post-operative month 1, but gastric emptying was not prolonged
after post-operative month 3 compared with the pre-operative
value. The A group continued accelerated gastric emptying after
post-operative month 3, whereas the VR group values were essen-
tially close to their own pre-operative values.
Nutritional parameters for 1 year after surgery
Post-operative backgrounds of the study subjects, such as under-
going of adjuvant chemotherapy and tumour recurrence within
the first postoperative year, were not significantly different
between the A and VR groups (Table 2).
The results of changes in post-operative nutritional para-
meters are shown in Fig. 4. Comparisons of the nutritional
biochemical parameters including serum albumin, total choles-
terol, haemoglobin-A1c and the N-benzoyl-L-tyrosyl-para-
aminobenzoic acid (BT-PABA) test were almost similar (Fig. 4a–d,
respectively). The values of serum albumin returned to the pre-
operative level at post-operative month 3, but the values of total
cholesterol and pancreatic functions continued to remain below
the pre-operative level during the first post-operative year in both
groups. Weight change in all patients from admission to operation
was -1.27 0.2 kg and was without significant difference between
the two groups (-1.18  0.3 kg in the A group versus -1.36 
0.3 kg in the VR group; P = 0.969). The results of changes in
post-operative patient weight are shown in Fig. 5. The post-
operative weight in both groups decreased at post-operative month
1 compared with the pre-operative weight and in both groups
gradually regained weight as time passed. Post-operative weight
loss in the A group was prolonged compared with that in the VR
group, and this tendency was observed at all post-operative time
points. The post-operative body weight recovered to nearly the
pre-operative weight in the VR group at 1 year after surgery. The
percentage of pre-operative weight in the VR group was signifi-
cantly greater than that in the A group at post-operative month 12
(A group: 93.8 1.2%, VR group: 98.5 1.3%, P = 0.015).
Discussion
The results from the present prospective, randomized, clinical trial
were that (i) the incidence of DGE was lower in an antecolic
duodenojejunostomy versus a vertical retrocolic duodenojejunos-
tomy, but the difference was not significant, (ii) gastric emptying
was more accelerated in the patients reconstructed with the
antecolic route for 1 year after surgery, and (iii) body weight gain
during the first year after surgery was superior in patients recon-
structed using the vertical retrocolic route.
The PPPD procedure was first described by Watson in
194420 and reintroduced by Traverso and Longmire in 197821
with the intent to improve post-operative nutritional status
and avoid postgastrectomy syndromes, and DGE was con-
sidered as a specific complication after PPPD attributed to
pylorus-sparing resection.4 The causative factors of DGE have
been widely debated. These include anastomotic ischaemia,
nerve damage, altered hormone levels, pylorospasm, gastric dys-
rhythmia, mechanical torsion and angularity, local inflam-
mation and abdominal complications.4,7,10,22–26 To prevent
or treat DGE after PPPD, the peri-operative use of prokinetic
agents or different operative techniques has been tested.4,5,27–30
These peri-operative management or operative procedures were
reported as possibly effective, but they have not gained wide
acceptance. Several reports support an association between the
reconstruction route used with PPPD and the incidence of
DGE.4–13,26–29 Two reconstruction routes are used for a duodeno-
jejunostomy during PPPD: the antecolic route and the retrocolic
route. Many of the previous studies have suggested that
the incidence of DGE is lower with an antecolic duodenojeju-
nostomy because it may decrease the risk of mechanical prob-
lems as a result of angulation or torsion of the relatively fixed
stomach.4–10 However, one randomized control trial11 and the
authors’ preliminary reports12,13 showed no significant difference
in the incidence of DGE between antecolic and retrocolic
reconstruction.
Although DGE occurrence in the VR group was higher than
that in the A group in the present study, the difference was not
statistically significant. Of note, the difference in DGE incidences
in this study may be underestimated by a lack of power (type II
error) because the number of patients was set on the basis of the
hypothesis that antecolic reconstruction decreases the rate of DGE
from 30% to 10%. However, the vertical retrocolic reconstruction
showed a lower incidence of DGE than was expected. The 10%
incidence of clinically relevant DGE with the authors’ vertical
retrocolic reconstruction method was much less than the 24%–
72% incidence reported with retrocolic reconstruction in previ-
ous reports6,8,9,11,24,29 and was comparable to the rates of 3–34%
reported with antecolic reconstruction.6–11,25,27,28,31,32 Two possible
reasons for the decreased occurrence of DGE with the authors’
vertical retrocolic reconstruction method include (i) the duode-
nojejunostomy and stomach were separate from the excisions and
the anastomotic field in the right upper quadrant and thus were
spared expected inflammation, and (ii) the vertical and straight
reconstruction avoided flexion and angulation of the stomach and
contributed to flow of gastric contents by gravity in the upright
position in patients.
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Gastric emptying as assessed by the results of T max and T 1/2
was more prolonged in the VR group than the A group at post-
operative month 1, but the difference was not significant. Most
patients in the VR group did not develop clinical problems includ-
ing the need for interventional treatment. At post-operative
months 3, 6, 9, and 12, the results of T max and T 1/2 were
essentially similar between the two groups, recovering close to the
pre-operative values. In contrast, gastric emptying as indicated by
the %dose/2h results was more accelerated in the A group than in
VR group patients, and the difference was significant at post-
operative month 6. In addition, the %dose/2 h results in the VR
group were essentially close to their own pre-operative values,
whereas those in the A group were higher than the pre-operative
values until post-operative month 12. These results imply that the
vertical retrocolic reconstruction may maintain more physiologi-
cal gastric emptying after surgery compared with the antecolic
reconstruction.
With regard to nutritional status in the present study, the values
of serum albumin returned to the pre-operative level at post-
operative month 3, but the values of total cholesterol continued to
remain below the pre-operative level during the first post-
operative year in both groups. These results were similar to those
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in previous reports.31,32 The changes in biochemical parameters
between the two groups were similar. In contrast, the patients in
the A group had a prolonged body weight loss compared with
those in the VR group. The factors relating to post-operative
weight gain after PPPD have been reported to be pancreatic
endocrine and exocrine function, disease, operative procedure,
intra- or post-operative chemoradiation therapy and tumour
recurrence.33–36 The nutritional parameters and tumour status
were similar between the two groups in the present study. Thus,
these results were difficult to explain in terms of the differences in
body weight change between the two reconstruction methods.
When the reason for the differences in body weight change
between the two reconstructions is considered, gastric emptying
may be highlighted. In a series of gastric surgeries, a pylorus-
preserving gastrectomy was reported to lead to slower gastric
emptying and better post-operative weight gain compared with a
conventional distal gastrectomy with Billroth I anastomosis.37,38 In
regard to bariatric surgeries, several reports suggested that opera-
tive procedures such as gastric Roux-en-Y bypass or sleeve gast-
rectomy may reduce weight owing to enhanced endogenous
release of anorexigenic gut peptides (cholecystokinin, glucagon-
like peptide-1, and polypeptide YY) by changing the acceleration
of gastric emptying and increasing delivery of nutrients to the
distal small intestine.39 In the present study, antecolic reconstruc-
tion is speculated to be potentially associated with prolonged
post-operative weight loss affected by accelerated gastric empty-
ing. However, the post-operative weight change is a result of mul-
tiple factors, and it may be difficult to explain weight change only
on the basis of the influence of gastric emptying. Furthermore,
post-operative patient eating habits and the status of health
including quality of life were not evaluated. Further analysis
focusing on post-operative nutritional status affected by subse-
quently changing gastrointestinal function such as gastric empty-
ing and the profile and response of gut peptides may be required.
In conclusion, the results of this prospective, randomized, clini-
cal trial showed that a vertical retrocolic duodenojejunostomy was
an acceptable procedure for a lower incidence of DGE. In addi-
tion, a vertical retrocolic duodenojejunostomy may result in a
better body weight recovery by maintaining moderate (not too
accelerated) gastric emptying compared with that of an antecolic
duodenojejunostomy. Although further studies are awaited, a ver-
tical retrocolic duodenojejunostomy is proposed as a potential
choice of reconstruction method in patients undergoing PPPD.
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